186 related articles for article (PubMed ID: 3083214)
1. Autoantibody testing: procedures and significance in systemic rheumatic diseases.
Fritzler MJ
Methods Achiev Exp Pathol; 1986; 12():224-60. PubMed ID: 3083214
[TBL] [Abstract][Full Text] [Related]
2. [Methods for determining antinuclear antibodies and their clinical significance].
Aeschlimann A; Meyer O; Kahn MF; Müller W
Schweiz Med Wochenschr; 1989 Dec; 119(48):1701-12. PubMed ID: 2694362
[TBL] [Abstract][Full Text] [Related]
3. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
Nakamura RM; Tan EM
Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
[TBL] [Abstract][Full Text] [Related]
4. Update on laboratory studies and relationship to rheumatic and allergic diseases.
McCarty GA
Ann Allergy; 1985 Sep; 55(3):421-33. PubMed ID: 2412470
[TBL] [Abstract][Full Text] [Related]
5. [Significance of antinuclear antibodies in rheumatology].
Ciobanu V; Boloşiu HD
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
[No Abstract] [Full Text] [Related]
6. [Detection of circulating anticellular antibodies by indirect immunofluorescence on HEp-2 cell substrates: study of the clinical value of rare fluorescence patterns].
Haberhauer G; Bröll H
Z Gesamte Inn Med; 1988 Jul; 43(14):377-80. PubMed ID: 3064447
[TBL] [Abstract][Full Text] [Related]
7. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
8. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
9. [Immunoserological area--with special reference to the current topics on antinuclear antibodies].
Moteki S; Yoshida H
Rinsho Byori; 1990 Jul; 38(7):765-72. PubMed ID: 2205741
[TBL] [Abstract][Full Text] [Related]
10. [Antinuclear antibodies in rheumatology].
Zuber M
Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
[TBL] [Abstract][Full Text] [Related]
11. Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice.
Cohen MG; Pollard KM; Schrieber L
Clin Exp Immunol; 1988 Apr; 72(1):50-4. PubMed ID: 3260838
[TBL] [Abstract][Full Text] [Related]
12. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
[TBL] [Abstract][Full Text] [Related]
13. Current status of tests for antinuclear antibodies (ANA) in rheumatic diseases.
Nakamura RN; Tan EM
West J Med; 1978 Jan; 128(1):51-2. PubMed ID: 415436
[No Abstract] [Full Text] [Related]
14. Laboratory diagnosis of systemic rheumatic disease.
Maehara KT
Am J Med Technol; 1983 Jul; 49(7):477-81. PubMed ID: 6194686
[No Abstract] [Full Text] [Related]
15. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
17. Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
Deng JS; Bair LW; Medsger TA; Sontheimer RA
Diagn Clin Immunol; 1987; 5(3):151-7. PubMed ID: 3121208
[TBL] [Abstract][Full Text] [Related]
18. [Determination of antinuclear antibodies in rheumatic diseases].
Endresen GK; Mellbye OJ
Tidsskr Nor Laegeforen; 1991 Feb; 111(6):716-9. PubMed ID: 2008695
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.
Tan EM; Smolen JS; McDougal JS; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; Reeves WH; Rothfield NF; Takasaki Y; Wiik A; Wilson M; Koziol JA
J Rheumatol; 2002 Jan; 29(1):68-74. PubMed ID: 11824974
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies against soluble nuclear antigens in rheumatic diseases].
Nikolov K; Baleva M
Vutr Boles; 1987; 26(5):112-7. PubMed ID: 3324484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
